ANAVASI Diagnostics
ANAVASI Diagnostics® is a privately-held company focused on providing innovative and leading diagnostic technology for the future of health care.
With the AscencioDx® COVID-19 Molecular Detector for COVID-19 and (soon) other respiratory viruses, Point of Care professionals can obtain PCR-equivalent results in about half an hour. FAST, AFFORDABLE and HIGHLY ACCURATE. Using NAAT RT-LAMP technology, the AscencioDx provides healthcare professionals with diagnostic results they can trust.
Confidently and securely transmit patient test results to our data portal using a QR code: no Bluetooth connection or APP download required. This reporting database can fully integrate with EHRs/LIMS and can also provide customizable “passport style” reports.
The AscencioDx® COVID 19 Molecular Diagnostic System has been submitted to the FDA for an Emergency Use Authorization and is currently in review. At present, it does not have an EUA, is not FDA 510k cleared, and is not commercially available.
Videos
AscencioDx® COVID 19 Molecular Diagnostic System
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesBusiness Needs:
Direct Sales, Distributor/Agent/Representative, Investor